Long Term Prophylactic Therapy of Congenital Long QT Syndrome Type III (LQT3) With Ranolazine
NCT01728025 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 10
Last updated 2015-03-26
Summary
The purpose of this study is to determine whether ranolazine will reduce the risk of arrhythmic events in patients with long QT syndrome type 3.
Conditions
- Long QT Syndrome Type 3
Interventions
- DRUG
-
Ranolazine
Sponsors & Collaborators
-
Tel-Aviv Sourasky Medical Center
lead OTHER_GOV
Study Design
- Allocation
- NA
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-10-31
- Primary Completion
- 2017-11-30
- Completion
- 2017-11-30
Countries
- Israel
Study Locations
More Related Trials
-
Proarrhythmic Medicines and Primary Cardiac Arrest
NCT00005253 ·Status: COMPLETED
-
Observational Study to Describe Health-Related Quality of Life and Measure Disease Burden Among Patients With Long QT Syndrome Types (LQTS) 2 and 3
NCT07075445 ·Status: RECRUITING
-
Exploring Mechanisms and Morphology of QT Interval Prolongation
NCT03291145 ·Status: COMPLETED ·Phase: NA
-
NOACs for Atrial Tachyarrhythmias in Congenital Heart Disease
NCT02928133 ·Status: UNKNOWN
-
Cardiac Resynchronization Therapy in Congenital Heart Defects
NCT00450684 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Electromechanical Profiling of the Long-QT Syndrome (LQTS)
NCT04074122 ·Status: UNKNOWN
-
Safety and Efficacy Aspects of a Standardized Stepwise Anatomical Approach for AVNRT Ablation
NCT02072473 ·Status: WITHDRAWN
-
Identification of Risk Factors for Arrhythmia in Children and Adolescents With Hypertrophic Cardiomyopathy
NCT00753233 ·Status: COMPLETED
-
Safety, Tolerability, and Exploratory Efficacy of AGP100 in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
NCT07263139 ·Status: RECRUITING ·Phase: PHASE2
-
LQT and Smartphone/Smartwatch
NCT04728100 ·Status: COMPLETED
-
DNA Analysis From Isolated Cardiomyocytes in the Molecular Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia
NCT03177018 ·Status: COMPLETED ·Phase: NA
-
Cardiac Rehabilitation of Children and Adolescent With Long QT Syndrome
NCT05964322 ·Status: COMPLETED
-
QT Interval in Athletes
NCT05759260 ·Status: COMPLETED
-
The Mechanism of Endogenous Nociceptin/Orphanin FQ(N/OFQ) and β1-adrenoceptor Autoantibody in Promoting Ischemic Arrhythmia in Rats
NCT06947551 ·Status: NOT_YET_RECRUITING
-
A TQT Study of Effect of M2951 on Cardiac Repolarization
NCT07214935 ·Status: COMPLETED ·Phase: PHASE1
-
Left Bundle Branch Pacing Versus Conventional Pacing in Atrioventricular Block
NCT05129098 ·Status: COMPLETED ·Phase: NA
-
Synchrony in Cardiac Conduction: Assessing the Effects of Pacing on Cardiac Performance Through Magnetic Resonance Imaging and Advanced ECG-imaging
NCT06843135 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Telemetric Arrhythmia and Syncope Diagnosis - Evaluation of Arrhythmia Treatment Efficacy
NCT01265303 ·Status: UNKNOWN ·Phase: NA
-
LVSP vs RVP in Patients With AV Conduction Disorders
NCT04595487 ·Status: RECRUITING ·Phase: NA
-
Optimizing Diagnostics Of Syncope Events Using Intelligent Telemetric Solutions.
NCT01265290 ·Status: UNKNOWN ·Phase: NA
-
The Effect of Low LEVel TrAgus STimulation on the Electrophysiological Substrate of Patients With Ischemic CardioMyopathy Substrate of Subjects With Ischemic CardioMyopathy
NCT03549468 ·Status: COMPLETED ·Phase: NA
-
Pathophysiologic Mechanism for Arrhythmias and Impaired Aerobic Capacity in Tetralogy of Fallot and Other Congenital Heart Diseases
NCT05122962 ·Status: RECRUITING
-
AV Nodal Reentrant Tachycardia Study
NCT00618683 ·Status: COMPLETED ·Phase: NA
-
Reverse RAMP Pacing to Terminate Ventricular Tachycardia ( REV-RAMP)
NCT03412240 ·Status: UNKNOWN ·Phase: NA
-
Comparison Between Epinephrine and Exercise Test in QT Long Syndrome Patients
NCT01745666 ·Status: UNKNOWN ·Phase: NA